PROPRANOLOL HYDROCHLORIDE

PROPRANOLOL HYDROCHLORIDE was reported 72996 times

These side effects are most commonly reported by patients taking PROPRANOLOL HYDROCHLORIDE:

# Side effect Count
0 OFF LABEL USE 8062
1 DRUG INEFFECTIVE 5738
2 NAUSEA 4665
3 HEADACHE 4040
4 FATIGUE 3993
5 DIARRHOEA 3358
6 DIZZINESS 3279
7 PRODUCT USE IN UNAPPROVED INDICATION 3193
8 VOMITING 2842
9 DYSPNOEA 2722
10 PRODUCT USE ISSUE 2613
11 PAIN 2470
12 TOXICITY TO VARIOUS AGENTS 2441
13 ANXIETY 2319
14 INSOMNIA 2292
15 FALL 2249
16 ASTHENIA 2123
17 SOMNOLENCE 2013
18 MALAISE 1998
19 HYPOTENSION 1993
20 CONDITION AGGRAVATED 1977
21 DRUG INTERACTION 1971
22 COMPLETED SUICIDE 1907
23 ARTHRALGIA 1860
24 TREMOR 1802
25 DEPRESSION 1801
26 ABDOMINAL PAIN 1639
27 MIGRAINE 1584
28 PYREXIA 1568
29 PRURITUS 1532
30 HYPERTENSION 1530
31 HYPERHIDROSIS 1509
32 COUGH 1473
33 BRADYCARDIA 1463
34 DECREASED APPETITE 1456
35 RASH 1439
36 OVERDOSE 1373
37 CONFUSIONAL STATE 1343
38 DRUG INTOLERANCE 1334
39 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1325
40 WEIGHT DECREASED 1317
41 FEELING ABNORMAL 1312
42 PNEUMONIA 1294
43 DEATH 1263
44 BLOOD PRESSURE INCREASED 1224
45 WEIGHT INCREASED 1193
46 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1174
47 CONSTIPATION 1158
48 PAIN IN EXTREMITY 1157
49 SUICIDAL IDEATION 1132
50 CARDIAC ARREST 1086
51 INTENTIONAL OVERDOSE 1071
52 ABDOMINAL PAIN UPPER 1051
53 MYALGIA 1051
54 ACUTE KIDNEY INJURY 1040
55 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1038
56 PRODUCT DOSE OMISSION ISSUE 1036
57 PALPITATIONS 1019
58 CHEST PAIN 1016
59 BACK PAIN 1009
60 PARAESTHESIA 1001
61 VISION BLURRED 980
62 HYPERSENSITIVITY 974
63 GAIT DISTURBANCE 957
64 NIGHTMARE 929
65 MUSCLE SPASMS 920
66 TACHYCARDIA 919
67 ANAEMIA 906
68 LOSS OF CONSCIOUSNESS 899
69 COMA 894
70 MEMORY IMPAIRMENT 877
71 SLEEP DISORDER 872
72 SEIZURE 864
73 DRUG HYPERSENSITIVITY 861
74 CARDIO-RESPIRATORY ARREST 857
75 SYNCOPE 853
76 URINARY TRACT INFECTION 851
77 ILLNESS 784
78 SEDATION 777
79 CHILLS 774
80 ALOPECIA 771
81 ABDOMINAL DISCOMFORT 745
82 HYPOAESTHESIA 745
83 HALLUCINATION 716
84 COVID-19 715
85 NEPHROLITHIASIS 715
86 AGITATION 708
87 NASOPHARYNGITIS 708
88 OEDEMA PERIPHERAL 696
89 PERIPHERAL SWELLING 693
90 HYPOGLYCAEMIA 692
91 INJECTION SITE PAIN 688
92 ERYTHEMA 678
93 HEART RATE INCREASED 670
94 SEPSIS 664
95 DEHYDRATION 652
96 SUICIDE ATTEMPT 643
97 CEREBROVASCULAR ACCIDENT 624
98 RENAL FAILURE 621
99 TINNITUS 607
100 MUSCULAR WEAKNESS 605
101 IRRITABILITY 579
102 TREATMENT FAILURE 577
103 BALANCE DISORDER 574
104 SWELLING FACE 570
105 ELECTROCARDIOGRAM QT PROLONGED 567
106 CHEST DISCOMFORT 560
107 MUSCULOSKELETAL STIFFNESS 559
108 GASTROOESOPHAGEAL REFLUX DISEASE 557
109 URTICARIA 551
110 DISTURBANCE IN ATTENTION 549
111 DRY MOUTH 544
112 ASCITES 537
113 LETHARGY 534
114 ABDOMINAL DISTENSION 527
115 STRESS 524
116 INFLUENZA 521
117 INCORRECT DOSE ADMINISTERED 513
118 EYE PAIN 511
119 DYSPEPSIA 506
120 JOINT SWELLING 506
121 DYSPHAGIA 504
122 SINUSITIS 491
123 CONTUSION 489
124 PANIC ATTACK 482
125 THROMBOCYTOPENIA 479
126 VISUAL IMPAIRMENT 479
127 GENERAL PHYSICAL HEALTH DETERIORATION 477
128 AMNESIA 476
129 DYSPHONIA 475
130 BLOOD GLUCOSE INCREASED 469
131 CHRONIC KIDNEY DISEASE 469
132 DIABETES MELLITUS 465
133 SWOLLEN TONGUE 456
134 HYPONATRAEMIA 454
135 ARTHRITIS 452
136 HAEMATEMESIS 448
137 SEROTONIN SYNDROME 443
138 OROPHARYNGEAL PAIN 439
139 VERTIGO 438
140 CARDIOGENIC SHOCK 436
141 FLUSHING 435
142 PULMONARY EMBOLISM 435
143 DEPRESSED LEVEL OF CONSCIOUSNESS 434
144 MYOCARDIAL INFARCTION 432
145 ASTHMA 431
146 BLOOD PRESSURE DECREASED 430
147 NEUTROPENIA 425
148 INTENTIONAL PRODUCT MISUSE 424
149 HOSPITALISATION 422
150 HEART RATE DECREASED 418
151 CONTRAINDICATED PRODUCT ADMINISTERED 417
152 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 413
153 ALTERED STATE OF CONSCIOUSNESS 412
154 NECK PAIN 412
155 ATRIAL FIBRILLATION 411
156 INFECTION 408
157 RESPIRATORY FAILURE 407
158 GASTROINTESTINAL DISORDER 403
159 PSORIASIS 403
160 WITHDRAWAL SYNDROME 403
161 ANGIOEDEMA 399
162 DRUG DOSE OMISSION 398
163 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 397
164 COGNITIVE DISORDER 389
165 ALANINE AMINOTRANSFERASE INCREASED 387
166 HAEMOGLOBIN DECREASED 382
167 HEPATIC ENZYME INCREASED 382
168 PERIPHERAL COLDNESS 378
169 AGGRESSION 377
170 DEPRESSED MOOD 377
171 HEAD DISCOMFORT 377
172 INTENTIONAL PRODUCT USE ISSUE 376
173 SWELLING 376
174 DIPLOPIA 373
175 EMOTIONAL DISTRESS 372
176 RHEUMATOID ARTHRITIS 372
177 BURNING SENSATION 369
178 RESTLESSNESS 364
179 CONVULSION 362
180 DRUG WITHDRAWAL SYNDROME 361
181 HYPERKALAEMIA 358
182 DYSARTHRIA 357
183 MATERNAL EXPOSURE DURING PREGNANCY 355
184 PHOTOPHOBIA 355
185 FOETAL EXPOSURE DURING PREGNANCY 353
186 DISORIENTATION 348
187 HAEMANGIOMA 348
188 PLATELET COUNT DECREASED 345
189 HAEMATURIA 344
190 BRONCHITIS 341
191 SPEECH DISORDER 338
192 BLINDNESS 335
193 EPISTAXIS 333
194 PRESYNCOPE 333
195 HOT FLUSH 332
196 INFUSION RELATED REACTION 332
197 MEDICATION ERROR 331
198 HYPOKALAEMIA 330
199 WHITE BLOOD CELL COUNT DECREASED 330
200 ADVERSE DRUG REACTION 327
201 MENTAL DISORDER 327
202 DISEASE RECURRENCE 326
203 ASPARTATE AMINOTRANSFERASE INCREASED 324
204 NERVOUSNESS 324
205 INJURY 323
206 AKATHISIA 322
207 METABOLIC ACIDOSIS 322
208 FEELING HOT 321
209 WHEEZING 320
210 PSYCHOTIC DISORDER 319
211 INFLUENZA LIKE ILLNESS 317
212 DYSKINESIA 315
213 SHOCK 314
214 RESPIRATORY ARREST 313
215 DRUG ABUSE 311
216 EAR INFECTION 311
217 HYPERTHYROIDISM 311
218 THERAPEUTIC RESPONSE DECREASED 311
219 DEEP VEIN THROMBOSIS 310
220 UNEVALUABLE EVENT 306
221 ARRHYTHMIA 304
222 TREATMENT NONCOMPLIANCE 304
223 RASH PRURITIC 303
224 HAEMORRHAGE 302
225 NEUROPATHY PERIPHERAL 302
226 DRY SKIN 300
227 NASAL CONGESTION 300
228 RHINORRHOEA 300
229 GASTROINTESTINAL HAEMORRHAGE 299
230 ARTHROPATHY 297
231 SURGERY 296
232 BLOOD CHOLESTEROL INCREASED 292
233 DISCOMFORT 292
234 RENAL IMPAIRMENT 290
235 HALLUCINATION, VISUAL 287
236 OSTEOARTHRITIS 287
237 CRYING 284
238 INJECTION SITE ERYTHEMA 284
239 ENCEPHALOPATHY 283
240 DYSGEUSIA 282
241 OXYGEN SATURATION DECREASED 281
242 ABNORMAL BEHAVIOUR 280
243 HAEMORRHAGIC STROKE 280
244 HEPATIC ENCEPHALOPATHY 277
245 PRODUCT QUALITY ISSUE 276
246 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 276
247 CARDIAC FAILURE CONGESTIVE 275
248 BLOOD CREATININE INCREASED 270
249 POISONING DELIBERATE 270
250 RENAL FAILURE ACUTE 269
251 ADVERSE EVENT 268
252 C-REACTIVE PROTEIN INCREASED 268
253 SINUS BRADYCARDIA 268
254 PANCREATITIS 266
255 ANAPHYLACTIC REACTION 265
256 CARDIAC DISORDER 262
257 FLATULENCE 262
258 THERAPEUTIC RESPONSE UNEXPECTED 261
259 UNRESPONSIVE TO STIMULI 261
260 INFLAMMATION 260
261 OCULAR DISCOMFORT 260
262 OEDEMA 260
263 APHASIA 257
264 CARDIAC FAILURE 256
265 THERAPY INTERRUPTED 251
266 HALLUCINATION, AUDITORY 250
267 PRODUCT SUBSTITUTION ISSUE 250
268 SLEEP APNOEA SYNDROME 250
269 RHABDOMYOLYSIS 248
270 HEPATIC CIRRHOSIS 246
271 POOR QUALITY SLEEP 245
272 GENERALISED OEDEMA 244
273 DRY EYE 241
274 MULTIPLE SCLEROSIS RELAPSE 241
275 THERAPEUTIC PRODUCT EFFECT DECREASED 240
276 MOBILITY DECREASED 238
277 ANGER 237
278 HYPOTHYROIDISM 237
279 HYPERSOMNIA 235
280 THROMBOSIS 235
281 SKIN ULCER 233
282 TARDIVE DYSKINESIA 232
283 SKIN EXFOLIATION 231
284 PULMONARY OEDEMA 230
285 CHOLELITHIASIS 229
286 DELIRIUM 228
287 UPPER RESPIRATORY TRACT INFECTION 228
288 AMAUROSIS FUGAX 226
289 FLUID RETENTION 226
290 EXPOSURE DURING PREGNANCY 225
291 HEPATIC FAILURE 223
292 CIRCULATORY COLLAPSE 222
293 EXTRAPYRAMIDAL DISORDER 222
294 HYPERGLYCAEMIA 222
295 URINARY INCONTINENCE 222
296 DRUG DEPENDENCE 221
297 CATARACT 220
298 PANCYTOPENIA 219
299 URINARY TRACT DISORDER 219
300 LIP SWELLING 218
301 SKIN DISCOLOURATION 217
302 BONE PAIN 216
303 ABNORMAL DREAMS 215
304 TYPE 2 DIABETES MELLITUS 215
305 BLISTER 214
306 THERAPY CESSATION 213
307 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 211
308 LEUKOPENIA 211
309 RESPIRATORY DISTRESS 211
310 PREMATURE BABY 210
311 RESTLESS LEGS SYNDROME 210
312 INJECTION SITE HAEMORRHAGE 209
313 DISEASE PROGRESSION 207
314 VENTRICULAR TACHYCARDIA 207
315 JAUNDICE 206
316 MOOD SWINGS 205
317 CELLULITIS 204
318 ROAD TRAFFIC ACCIDENT 203
319 MENTAL STATUS CHANGES 201
320 OSTEOPOROSIS 201
321 GASTRITIS 200
322 HEAD INJURY 200
323 INTENTIONAL SELF-INJURY 200
324 INFANTILE SPITTING UP 199
325 POLLAKIURIA 199
326 HAEMATOCHEZIA 197
327 MIDDLE INSOMNIA 197
328 PRODUCT ADMINISTRATION INTERRUPTED 196
329 DYSURIA 195
330 NO ADVERSE EVENT 194
331 ORTHOSTATIC HYPOTENSION 194
332 EPILEPSY 193
333 HEPATITIS 192
334 MULTIPLE SCLEROSIS 192
335 PLEURAL EFFUSION 192
336 URINARY RETENTION 191
337 ACCIDENTAL OVERDOSE 190
338 THROAT IRRITATION 190
339 BRAIN INJURY 189
340 VIRAL INFECTION 187
341 HYPOXIA 186
342 PULMONARY FIBROSIS 186
343 ULCER 186
344 FEAR 185
345 PALLOR 185
346 PARANOIA 185
347 AGRANULOCYTOSIS 184
348 FIBROMYALGIA 183
349 GENERALISED TONIC-CLONIC SEIZURE 183
350 THINKING ABNORMAL 182
351 TRANSIENT ISCHAEMIC ATTACK 182
352 MUSCULOSKELETAL PAIN 181
353 PRODUCT DOSE OMISSION 181
354 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 180
355 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 180
356 PNEUMONIA ASPIRATION 179
357 WHITE BLOOD CELL COUNT INCREASED 179
358 MYDRIASIS 178
359 BLOOD CREATINE PHOSPHOKINASE INCREASED 177
360 RECTAL HAEMORRHAGE 177
361 THERAPY NON-RESPONDER 177
362 CYANOSIS 175
363 FEBRILE NEUTROPENIA 175
364 INJECTION SITE SWELLING 174
365 INJECTION SITE BRUISING 173
366 MENTAL IMPAIRMENT 173
367 BLOOD TRIGLYCERIDES INCREASED 171
368 DRUG LEVEL INCREASED 171
369 MANIA 171
370 MOOD ALTERED 171
371 ANHEDONIA 170
372 HYPERCALCAEMIA 170
373 LACTIC ACIDOSIS 170
374 MUSCLE TWITCHING 170
375 DELUSION 169
376 PRE-EXISTING CONDITION IMPROVED 169
377 RED BLOOD CELL SEDIMENTATION RATE INCREASED 169
378 STOMATITIS 168
379 CROHN^S DISEASE 167
380 GAIT INABILITY 167
381 NIGHT SWEATS 167
382 BASAL CELL CARCINOMA 166
383 EYE IRRITATION 166
384 MALIGNANT NEOPLASM PROGRESSION 166
385 CYSTITIS 165
386 LIVER FUNCTION TEST ABNORMAL 165
387 EMOTIONAL DISORDER 164
388 ERECTILE DYSFUNCTION 164
389 HEPATIC STEATOSIS 164
390 BLOOD POTASSIUM DECREASED 163
391 LIMB DISCOMFORT 163
392 BLOOD BILIRUBIN INCREASED 162
393 NEURALGIA 162
394 DYSTONIA 161
395 MYOCLONUS 161
396 BRAIN FOG 160
397 LIVER DISORDER 160
398 PULSELESS ELECTRICAL ACTIVITY 160
399 DRUG ERUPTION 159
400 INJECTION SITE PRURITUS 159
401 MULTIPLE ORGAN DYSFUNCTION SYNDROME 159
402 RASH ERYTHEMATOUS 159
403 DYSPNOEA EXERTIONAL 158
404 EYE SWELLING 158
405 PRESCRIBED UNDERDOSE 158
406 SEPTIC SHOCK 158
407 ACCIDENTAL EXPOSURE TO PRODUCT 157
408 HEART RATE IRREGULAR 157
409 PRODUCTIVE COUGH 157
410 INTENTIONAL DOSE OMISSION 156
411 MELAENA 156
412 HYPOPHAGIA 155
413 DYSSTASIA 154
414 ILL-DEFINED DISORDER 154
415 APATHY 153
416 SYNOVITIS 153
417 INJECTION SITE REACTION 152
418 DEAFNESS 151
419 ECZEMA 151
420 HERPES ZOSTER 151
421 INTERVERTEBRAL DISC PROTRUSION 151
422 OCULAR HYPERAEMIA 151
423 SINUS TACHYCARDIA 151
424 HAEMORRHOIDS 150
425 STAPHYLOCOCCAL INFECTION 150
426 NEUROLEPTIC MALIGNANT SYNDROME 149
427 THROAT TIGHTNESS 149
428 ANGINA PECTORIS 148
429 FEELING COLD 148
430 PHOTOSENSITIVITY REACTION 148
431 ACNE 147
432 HYPERLIPIDAEMIA 147
433 BLOOD GLUCOSE DECREASED 146
434 RENAL INJURY 146
435 BLOOD ALKALINE PHOSPHATASE INCREASED 145
436 HYPOACUSIS 143
437 IMPAIRED GASTRIC EMPTYING 143
438 SKIN BURNING SENSATION 143
439 SUSPECTED SUICIDE 143
440 UNDERDOSE 143
441 PSORIATIC ARTHROPATHY 142
442 RHEUMATOID FACTOR POSITIVE 142
443 BLOOD PRESSURE FLUCTUATION 141
444 DRUG EFFECT DECREASED 141
445 PAIN IN JAW 140
446 DISSOCIATION 139
447 PHARMACEUTICAL PRODUCT COMPLAINT 139
448 RENAL DISORDER 139
449 OBESITY 138
450 PARKINSONISM 137
451 SALIVARY HYPERSECRETION 137
452 ANURIA 136
453 COLD SWEAT 136
454 COLITIS 136
455 RESPIRATORY DEPRESSION 136
456 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 135
457 LEUKOCYTOSIS 135
458 MOVEMENT DISORDER 135
459 PANCREATITIS ACUTE 135
460 LYMPHADENOPATHY 134
461 VARICES OESOPHAGEAL 134
462 PARKINSON^S DISEASE 133
463 BIPOLAR DISORDER 132
464 BLOOD SODIUM DECREASED 132
465 EATING DISORDER 132
466 FUNGAL INFECTION 132
467 NERVOUS SYSTEM DISORDER 131
468 CHROMATURIA 130
469 INTESTINAL OBSTRUCTION 130
470 THERAPEUTIC RESPONSE SHORTENED 130
471 CHOLESTASIS 129
472 GASTROENTERITIS VIRAL 129
473 RIB FRACTURE 129
474 LUNG DISORDER 128
475 RED BLOOD CELL COUNT DECREASED 128
476 PSYCHOMOTOR HYPERACTIVITY 127
477 RESPIRATORY DISORDER 127
478 PRESCRIBED OVERDOSE 126
479 RASH MACULAR 126
480 RESPIRATORY SYNCYTIAL VIRUS INFECTION 126
481 LIMB INJURY 125
482 DRUG EXPOSURE DURING PREGNANCY 124
483 IMPAIRED WORK ABILITY 124
484 TORSADE DE POINTES 124
485 GASTRIC ULCER 123
486 INCREASED APPETITE 123
487 DEVICE MALFUNCTION 122
488 DRUG TOXICITY 122
489 INSURANCE ISSUE 122
490 LACRIMATION INCREASED 121
491 SLEEP TERROR 121
492 BLOOD PRESSURE ABNORMAL 120
493 JOINT INJURY 120
494 OBSESSIVE-COMPULSIVE DISORDER 120
495 BREATH SOUNDS ABNORMAL 119
496 MULTI-ORGAN FAILURE 119
497 SKIN LESION 119
498 ABORTION SPONTANEOUS 118
499 CEREBRAL INFARCTION 118
500 HEPATIC FUNCTION ABNORMAL 118
501 DEVICE ISSUE 117
502 ECONOMIC PROBLEM 117
503 EYE DISORDER 116
504 JOINT STIFFNESS 116
505 SKIN NECROSIS 116
506 PHARYNGEAL SWELLING 115
507 DERMATITIS 113
508 INITIAL INSOMNIA 113
509 ISCHAEMIC STROKE 113
510 OESOPHAGEAL VARICES HAEMORRHAGE 113
511 VISUAL ACUITY REDUCED 113
512 ABASIA 112
513 BREAST CANCER 112
514 EYE PRURITUS 112
515 HYPOTHERMIA 112
516 IRRITABLE BOWEL SYNDROME 112
517 SKIN DISORDER 112
518 ANAPHYLACTIC SHOCK 111
519 BODY TEMPERATURE INCREASED 111
520 DIABETIC KETOACIDOSIS 111
521 MUSCULOSKELETAL DISCOMFORT 111
522 ACTIVITIES OF DAILY LIVING IMPAIRED 110
523 HIP FRACTURE 110
524 RHEUMATOID NODULE 110
525 ATRIOVENTRICULAR BLOCK 109
526 BLOOD PARATHYROID HORMONE DECREASED 109
527 CEREBRAL HAEMORRHAGE 109
528 GAMMA-GLUTAMYLTRANSFERASE INCREASED 109
529 HAEMATOCRIT DECREASED 109
530 IMPAIRED QUALITY OF LIFE 109
531 LOWER RESPIRATORY TRACT INFECTION 109
532 NEOPLASM MALIGNANT 109
533 SENSORY DISTURBANCE 109
534 SUPRAVENTRICULAR TACHYCARDIA 109
535 PANNICULITIS 108
536 PRODUCT PHYSICAL ISSUE 108
537 UPPER GASTROINTESTINAL HAEMORRHAGE 108
538 CARDIOMEGALY 107
539 CORONARY ARTERY DISEASE 107
540 FAECES DISCOLOURED 107
541 FEELING JITTERY 107
542 GASTRIC DISORDER 107
543 RESPIRATORY TRACT INFECTION 107
544 VENTRICULAR FIBRILLATION 107
545 COORDINATION ABNORMAL 106
546 RETCHING 106
547 EXTRA DOSE ADMINISTERED 105
548 HIATUS HERNIA 105
549 HYPOTONIA 105
550 FOETAL GROWTH RESTRICTION 104
551 FOOT FRACTURE 104
552 DERMATITIS ATOPIC 103
553 DIVERTICULITIS 103
554 GRANULOMA SKIN 103
555 INTERVERTEBRAL DISC DEGENERATION 103
556 ORAL PAIN 103
557 HYPOKINESIA 102
558 HYPOMAGNESAEMIA 102
559 INJECTION SITE MASS 102
560 MITRAL VALVE INCOMPETENCE 102
561 MOUTH ULCERATION 102
562 MUSCLE RIGIDITY 102
563 POISONING 102
564 THYROID DISORDER 102
565 ATRIOVENTRICULAR BLOCK FIRST DEGREE 101
566 COLITIS ULCERATIVE 101
567 DRUG TITRATION ERROR 101
568 EAR PAIN 101
569 SEASONAL ALLERGY 101
570 TRICUSPID VALVE INCOMPETENCE 101
571 ABDOMINAL PAIN LOWER 100
572 BRUXISM 100
573 FEEDING DISORDER 100
574 HAEMOPTYSIS 100
575 MUSCLE TIGHTNESS 100
576 PRODUCT PRESCRIBING ERROR 100
577 SCHIZOPHRENIA 100
578 VAGINAL HAEMORRHAGE 100
579 HAEMATOMA 99
580 HAEMODYNAMIC INSTABILITY 99
581 BLOOD UREA INCREASED 98
582 SYSTEMIC LUPUS ERYTHEMATOSUS 98
583 THIRST 98
584 ACUTE RESPIRATORY FAILURE 97
585 PARADOXICAL DRUG REACTION 97
586 ACUTE RESPIRATORY DISTRESS SYNDROME 96
587 BLOOD PRESSURE SYSTOLIC INCREASED 96
588 BONE DISORDER 96
589 POST-TRAUMATIC STRESS DISORDER 96
590 VENTRICULAR EXTRASYSTOLES 96
591 NOCTURIA 95
592 AMMONIA INCREASED 94
593 FACIAL PARALYSIS 94
594 WRONG TECHNIQUE IN DRUG USAGE PROCESS 94
595 AREFLEXIA 93
596 DRUG EFFECT INCOMPLETE 93
597 HYPERTENSIVE CRISIS 93
598 INTERNATIONAL NORMALISED RATIO INCREASED 93
599 AFFECTIVE DISORDER 92
600 BEDRIDDEN 92
601 DRUG-INDUCED LIVER INJURY 92
602 GLAUCOMA 92
603 HUNGER 92
604 LIVER INJURY 92
605 NEUTROPHIL COUNT DECREASED 92
606 ROTATOR CUFF SYNDROME 92
607 SEXUAL DYSFUNCTION 92
608 TOOTH DISORDER 92
609 TUBULOINTERSTITIAL NEPHRITIS 92
610 DISABILITY 91
611 DRUG RESISTANCE 91
612 EJECTION FRACTION DECREASED 91
613 IMPAIRED HEALING 91
614 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 91
615 SCAR 91
616 SOMNAMBULISM 91
617 TOOTHACHE 91
618 ANKLE FRACTURE 90
619 DIABETES MELLITUS INADEQUATE CONTROL 90
620 SKIN CANCER 90
621 THYROTOXIC CRISIS 90
622 ACUTE MYOCARDIAL INFARCTION 89
623 CANDIDA INFECTION 89
624 CHOKING 89
625 STATUS EPILEPTICUS 89
626 TRANSAMINASES INCREASED 89
627 ATAXIA 88
628 BLOOD THYROID STIMULATING HORMONE INCREASED 88
629 CARDIOTOXICITY 88
630 COAGULOPATHY 88
631 DRUG ADMINISTRATION ERROR 88
632 NEPHROPATHY TOXIC 88
633 PARAESTHESIA ORAL 88
634 AMENORRHOEA 87
635 CONCUSSION 87
636 END STAGE RENAL DISEASE 87
637 FREQUENT BOWEL MOVEMENTS 87
638 GINGIVAL BLEEDING 87
639 INTERSTITIAL LUNG DISEASE 87
640 SINUS DISORDER 87
641 SPLENOMEGALY 87
642 BRONCHOSPASM 86
643 DIZZINESS POSTURAL 86
644 MAJOR DEPRESSION 86
645 MYOCARDIAL ISCHAEMIA 86
646 ORAL DISCOMFORT 86
647 PANIC REACTION 86
648 RASH GENERALISED 86
649 EAR DISCOMFORT 85
650 HEMIPARESIS 85
651 UPPER LIMB FRACTURE 85
652 BLOOD URINE PRESENT 84
653 FACIAL PAIN 84
654 LOWER LIMB FRACTURE 84
655 MIGRAINE WITH AURA 84
656 NEEDLE ISSUE 84
657 SPINAL OSTEOARTHRITIS 84
658 CARPAL TUNNEL SYNDROME 83
659 COMA SCALE ABNORMAL 83
660 DERMATITIS CONTACT 83
661 HYPERBILIRUBINAEMIA 83
662 IMPAIRED DRIVING ABILITY 83
663 KIDNEY INFECTION 83
664 MYOCARDITIS 83
665 OSTEOPENIA 83
666 AGEUSIA 82
667 BODY TEMPERATURE DECREASED 82
668 GALLBLADDER DISORDER 82
669 HEPATOTOXICITY 82
670 HERNIA 82
671 LOW BIRTH WEIGHT BABY 82
672 PRODUCT PRESCRIBING ISSUE 82
673 PULMONARY HYPERTENSION 82
674 RASH MACULO-PAPULAR 82
675 EOSINOPHILIA 81
676 ESSENTIAL TREMOR 81
677 FEMUR FRACTURE 81
678 LABORATORY TEST ABNORMAL 81
679 PERICARDIAL EFFUSION 81
680 PRODUCT DOSE OMISSION IN ERROR 81
681 WOUND 81
682 DENTAL CARIES 80
683 DRUG TOLERANCE DECREASED 80
684 EYE HAEMORRHAGE 80
685 IMMUNODEFICIENCY 80
686 PRODUCT AVAILABILITY ISSUE 80
687 SNEEZING 80
688 BACK DISORDER 79
689 ERUCTATION 79
690 GLOSSODYNIA 79
691 OESOPHAGITIS 79
692 PARALYSIS 79
693 PHARYNGEAL OEDEMA 79
694 ANOREXIA 78
695 DRUG LEVEL BELOW THERAPEUTIC 78
696 PAIN OF SKIN 78
697 PROCEDURAL PAIN 78
698 SUICIDAL BEHAVIOUR 78
699 BURSITIS 77
700 DEMENTIA 77
701 GASTROENTERITIS 77
702 HALLUCINATIONS, MIXED 77
703 HEPATOCELLULAR CARCINOMA 77
704 HYPOCALCAEMIA 77
705 MYOPATHY 77
706 SELF-INJURIOUS IDEATION 77
707 TENDERNESS 77
708 APNOEA 76
709 GRANULOCYTOPENIA 76
710 HEMIPLEGIA 76
711 JOINT DISLOCATION 76
712 PERSONALITY CHANGE 76
713 PNEUMOTHORAX 76
714 RENAL PAIN 76
715 ARTERIOSCLEROSIS CORONARY ARTERY 75
716 INCORRECT DRUG ADMINISTRATION DURATION 75
717 INTENTIONAL DRUG MISUSE 75
718 MOTOR DYSFUNCTION 75
719 PREMATURE DELIVERY 75
720 PRODUCT STORAGE ERROR 75
721 PRURITUS GENERALISED 75
722 QUALITY OF LIFE DECREASED 75
723 SLUGGISHNESS 75
724 CLOSTRIDIUM DIFFICILE INFECTION 74
725 LIBIDO DECREASED 74
726 SCREAMING 74
727 TEARFULNESS 74
728 TEMPERATURE INTOLERANCE 74
729 BLOOD IRON DECREASED 73
730 LOCALISED INFECTION 73
731 ARTERIOSCLEROSIS 72
732 CARDIAC MURMUR 72
733 GLYCOSYLATED HAEMOGLOBIN INCREASED 72
734 HYPERTHERMIA 72
735 MALNUTRITION 72
736 MULTIPLE DRUG OVERDOSE 72
737 PSYCHIATRIC SYMPTOM 72
738 STEVENS-JOHNSON SYNDROME 72
739 THERAPY PARTIAL RESPONDER 72
740 WRIST FRACTURE 72
741 AFFECT LABILITY 71
742 EXPIRED PRODUCT ADMINISTERED 71
743 FACE OEDEMA 71
744 HYPOGLYCAEMIC SEIZURE 71
745 LOCAL SWELLING 71
746 MATERNAL DRUGS AFFECTING FOETUS 71
747 PRODUCT ADMINISTRATION ERROR 71
748 VITAMIN D DEFICIENCY 71
749 BLOOD POTASSIUM INCREASED 70
750 DROOLING 70
751 FEELING DRUNK 70
752 GRAND MAL CONVULSION 70
753 POST PROCEDURAL COMPLICATION 70
754 ABSCESS 69
755 HYPERCHOLESTEROLAEMIA 69
756 INFUSION SITE PAIN 69
757 LYMPHOCYTE COUNT DECREASED 69
758 MENSTRUATION IRREGULAR 69
759 PULMONARY CONGESTION 69
760 TASTE DISORDER 69
761 BLOOD PRESSURE SYSTOLIC DECREASED 68
762 CHOLECYSTECTOMY 68
763 DEVICE DISLOCATION 68
764 GASTROINTESTINAL PAIN 68
765 HEPATOCELLULAR INJURY 68
766 MICTURITION URGENCY 68
767 MUSCULOSKELETAL CHEST PAIN 68
768 NERVE INJURY 68
769 OSTEONECROSIS 68
770 PROTEINURIA 68
771 SUDDEN DEATH 68
772 ABNORMAL WEIGHT GAIN 67
773 SCIATICA 67
774 SINUS CONGESTION 67
775 ADRENAL INSUFFICIENCY 66
776 BLOOD LACTIC ACID INCREASED 66
777 CARDIOMYOPATHY 66
778 DRUG EFFECT LESS THAN EXPECTED 66
779 HEAVY MENSTRUAL BLEEDING 66
780 HEPATITIS C 66
781 HEPATOMEGALY 66
782 HYPOAESTHESIA ORAL 66
783 SNORING 66
784 TOOTH FRACTURE 66
785 TOOTH INFECTION 66
786 BUNDLE BRANCH BLOCK RIGHT 65
787 INJECTION SITE RASH 65
788 TOXIC EPIDERMAL NECROLYSIS 65
789 CONJUNCTIVITIS 64
790 GOUT 64
791 INCONTINENCE 64
792 KNEE ARTHROPLASTY 64
793 NEOVASCULARISATION 64
794 OSTEOMYELITIS 64
795 RENAL TUBULAR NECROSIS 64
796 RESPIRATORY ACIDOSIS 64
797 VENTRICULAR ARRHYTHMIA 64
798 ANAL INCONTINENCE 63
799 ASPIRATION 63
800 ATELECTASIS 63
801 ATRIOVENTRICULAR BLOCK COMPLETE 63
802 CARDIAC FLUTTER 63
803 CARDIOVASCULAR DISORDER 63
804 HYPERREFLEXIA 63
805 LIGAMENT SPRAIN 63
806 RASH PAPULAR 63
807 BREAST CANCER FEMALE 62
808 DRUG DOSE OMISSION BY DEVICE 62
809 ELECTROLYTE IMBALANCE 62
810 EYE MOVEMENT DISORDER 62
811 INCREASED TENDENCY TO BRUISE 62
812 MUCOSAL INFLAMMATION 62
813 PORTAL HYPERTENSION 62
814 VISUAL FIELD DEFECT 62
815 BRAIN OEDEMA 61
816 CEREBRAL DISORDER 61
817 COLITIS ISCHAEMIC 61
818 DISSEMINATED INTRAVASCULAR COAGULATION 61
819 DRY THROAT 61
820 ENURESIS 61
821 HEPATIC CYTOLYSIS 61
822 HYPERACUSIS 61
823 RAYNAUD^S PHENOMENON 61
824 TRISMUS 61
825 FRACTURE 60
826 LIVER FUNCTION TEST INCREASED 60
827 MUSCULOSKELETAL DISORDER 60
828 PHARYNGITIS STREPTOCOCCAL 60
829 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 60
830 PRODUCT USED FOR UNKNOWN INDICATION 60
831 TACHYPNOEA 60
832 TOOTH LOSS 60
833 URINE ODOUR ABNORMAL 60
834 DECREASED ACTIVITY 59
835 DIABETIC NEUROPATHY 59
836 DRUG LEVEL DECREASED 59
837 EUPHORIC MOOD 59
838 EXTRASYSTOLES 59
839 HAEMORRHAGE INTRACRANIAL 59
840 IRON DEFICIENCY ANAEMIA 59
841 PRODUCT USE COMPLAINT 59
842 RETINAL DETACHMENT 59
843 SMALL INTESTINAL OBSTRUCTION 59
844 APPLICATION SITE ERYTHEMA 58
845 BLEPHAROSPASM 58
846 FOOT DEFORMITY 58
847 HYPOVOLAEMIC SHOCK 58
848 INCORRECT PRODUCT ADMINISTRATION DURATION 58
849 MASS 58
850 MUSCLE ATROPHY 58
851 SKIN IRRITATION 58
852 APHONIA 57
853 BACK INJURY 57
854 BLOOD CALCIUM DECREASED 57
855 CAESAREAN SECTION 57
856 COMMUNICATION DISORDER 57
857 DIVERTICULUM 57
858 DRUG SCREEN POSITIVE 57
859 EYELID PTOSIS 57
860 HAIR TEXTURE ABNORMAL 57
861 HEPATORENAL SYNDROME 57
862 INCOHERENT 57
863 MEDICATION OVERUSE HEADACHE 57
864 OSTEONECROSIS OF JAW 57
865 PLASMA CELL MYELOMA 57
866 PRODUCT DISPENSING ERROR 57
867 RESPIRATORY TRACT CONGESTION 57
868 TOOTH ABSCESS 57
869 VITREOUS FLOATERS 57
870 ANTIPSYCHOTIC DRUG LEVEL INCREASED 56
871 BACTERIAL INFECTION 56
872 BLOOD ALBUMIN DECREASED 56
873 DEVICE BREAKAGE 56
874 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 56
875 LEFT VENTRICULAR HYPERTROPHY 56
876 PORTAL VEIN THROMBOSIS 56
877 SUBDURAL HAEMATOMA 56
878 BONE DENSITY DECREASED 55
879 DISTRIBUTIVE SHOCK 55
880 DRUG TOLERANCE 55
881 ELECTROCARDIOGRAM ABNORMAL 55
882 FLANK PAIN 55
883 INABILITY TO AFFORD MEDICATION 55
884 METABOLIC DISORDER 55
885 NODULE 55
886 OTITIS MEDIA 55
887 PETECHIAE 55
888 PLATELET COUNT INCREASED 55
889 SCOLIOSIS 55
890 SKIN FISSURES 55
891 TENDONITIS 55
892 VITAMIN D DECREASED 55
893 ACUTE HEPATIC FAILURE 54
894 BREAST PAIN 54
895 DERMATITIS BULLOUS 54
896 DYSGRAPHIA 54
897 GROIN PAIN 54
898 PREGNANCY 54
899 SKIN LACERATION 54
900 APPLICATION SITE PRURITUS 53
901 CHOLECYSTITIS CHRONIC 53
902 DEVICE DIFFICULT TO USE 53
903 EMPHYSEMA 53
904 FORMICATION 53
905 HYPOMANIA 53
906 INJECTION SITE URTICARIA 53
907 MENORRHAGIA 53
908 RESPIRATORY RATE DECREASED 53
909 SOCIAL AVOIDANT BEHAVIOUR 53
910 SPINAL FRACTURE 53
911 BLOOD LACTATE DEHYDROGENASE INCREASED 52
912 BRADYPHRENIA 52
913 CLOSTRIDIUM DIFFICILE COLITIS 52
914 DERMATITIS ALLERGIC 52
915 ECCHYMOSIS 52
916 GASTRIC HAEMORRHAGE 52
917 MUSCLE SPASTICITY 52
918 NEOPLASM PROGRESSION 52
919 PHOTOPSIA 52
920 POLYURIA 52
921 ABNORMAL FAECES 51
922 BLOOD MAGNESIUM DECREASED 51
923 CORONARY ARTERY OCCLUSION 51
924 EXPOSURE VIA SKIN CONTACT 51
925 HYPERVENTILATION 51
926 HYPOPHOSPHATAEMIA 51
927 LOSS OF LIBIDO 51
928 PERITONITIS 51
929 PNEUMONITIS 51
930 REVERSIBLE AIRWAYS OBSTRUCTION 51
931 SOPOR 51
932 SPINAL OPERATION 51
933 STREPTOCOCCAL INFECTION 51
934 BLOOD THYROID STIMULATING HORMONE DECREASED 50
935 BODY HEIGHT DECREASED 50
936 DEPERSONALISATION/DEREALISATION DISORDER 50
937 DYSPHEMIA 50
938 FULL BLOOD COUNT DECREASED 50
939 GLOMERULAR FILTRATION RATE DECREASED 50
940 LIVE BIRTH 50
941 NEOPLASM SKIN 50
942 NEPHROGENIC ANAEMIA 50
943 PANIC DISORDER 50
944 PHARYNGITIS 50
945 SPINAL DISORDER 50
946 ULCERATED HAEMANGIOMA 50
947 UPPER-AIRWAY COUGH SYNDROME 50
948 ALCOHOL INTERACTION 49
949 AORTIC VALVE INCOMPETENCE 49
950 APPETITE DISORDER 49
951 AUTOIMMUNE DISORDER 49
952 BRAIN DEATH 49
953 CATATONIA 49
954 CEREBRAL ARTERY THROMBOSIS 49
955 FEELING OF BODY TEMPERATURE CHANGE 49
956 GOITRE 49
957 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 49
958 METASTASES TO LIVER 49
959 PRODUCT ADHESION ISSUE 49
960 TENSION HEADACHE 49
961 BLADDER DISORDER 48
962 CHOLECYSTITIS ACUTE 48
963 CYTOMEGALOVIRUS INFECTION 48
964 DEPENDENCE 48
965 DEVICE EXPULSION 48
966 GASTROINTESTINAL MOTILITY DISORDER 48
967 GYNAECOMASTIA 48
968 HYSTERECTOMY 48
969 LEFT VENTRICULAR DYSFUNCTION 48
970 LYMPHOPENIA 48
971 MASTOIDITIS 48
972 MUSCLE CONTRACTIONS INVOLUNTARY 48
973 NEUTROPHIL COUNT INCREASED 48
974 ORAL CANDIDIASIS 48
975 PHONOPHOBIA 48
976 SINUS HEADACHE 48
977 SKIN HAEMORRHAGE 48
978 WOUND INFECTION 48
979 BRAIN SCAN ABNORMAL 47
980 DEVICE LEAKAGE 47
981 DRUG DISPENSING ERROR 47
982 DUODENAL ULCER 47
983 HEREDITARY ANGIOEDEMA 47
984 MIOSIS 47
985 MULTIPLE DRUG OVERDOSE INTENTIONAL 47
986 NEUROLOGICAL SYMPTOM 47
987 ORAL HERPES 47
988 PHAEOCHROMOCYTOMA 47
989 PRODUCT TASTE ABNORMAL 47
990 RENAL CYST 47
991 TROPONIN INCREASED 47
992 WEIGHT FLUCTUATION 47
993 WRONG PRODUCT ADMINISTERED 47
994 AGORAPHOBIA 46
995 ALCOHOLISM 46
996 ANOSMIA 46
997 BONE MARROW FAILURE 46
998 DECREASED INTEREST 46
999 GRAVES^ DISEASE 46